Delay is a death sentence. Why rare disease families don’t trust Trump’s FDA nominee

Published September 24, 2026 10:36am ET | Updated September 24, 2026 10:36am ET



We call it the “rare disease community,” but there is nothing rare about the number of Americans whose lives are touched by these diseases.

Cancer afflicts 18 million Americans. Comparatively, an estimated 30 million Americans — roughly 1 in 10 — live with a rare disease. Individually, the more than 7,000 rare diseases affect relatively small populations, but collectively, rare disease patients represent one of the largest and most vulnerable constituencies in America. 

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.